JULIE DUNLAP: Open Payments
NPI 1811442239 · CHESTERTOWN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$772 in 37 payments from 19 companies in 2025. Trend: 2023 $1,066 · 2024 $975 · 2025 $772
Food & beverage: $772
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $116 |
| PFIZER INC. | 4 | $83 |
| Astellas Pharma US Inc | 3 | $80 |
| Lundbeck LLC | 3 | $67 |
| Amgen Inc. | 4 | $64 |
| ABBVIE INC. | 3 | $56 |
| Merck Sharp & Dohme LLC | 2 | $45 |
| Lilly USA, LLC | 2 | $44 |
| Dexcom, Inc. | 2 | $39 |
| Exact Sciences Corporation | 1 | $23 |
Products named: Kerendia, REXULTI, Veozah, VRAYLAR, GARDASIL 9, OTEZLA, PREVNAR 20, Dexcom G6 Transmitter.
Industry payments across MD — which companies pay providers there.
